Legal Representation
Attorney
Scott D. Woldow
USPTO Deadlines
Next Deadline
1435 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20231128)
Due Date
November 28, 2029
Grace Period Ends
May 28, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 28, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Nov 28, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Oct 24, 2023 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Oct 23, 2023 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Sep 28, 2023 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Sep 19, 2023 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Sep 25, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Sep 19, 2023 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Mar 21, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 17, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 17, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Mar 17, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 11, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 16, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 16, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 27, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 7, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 5, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 9, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 8, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of autoimmune diseases, illnesses, and conditions
First Use Anywhere:
Jul 1, 2023
First Use in Commerce:
Jul 1, 2023
Classification
International Classes
005